Ethiopian Clinical Trial Finds Fluorometholone Ineffective for Postoperative Trachomatous Trichiasisby GOAI Share ToA clinical trial conducted in Ethiopia involving over 2,400 participants examined the effectiveness of a topical anti-inflammatory treatment, fluorometholone, in addressing postoperative trachomatous trichiasis. Researchers led by Dr. John Kempen from Mass Eye and Ear determined that the treatment did not reduce the condition, which is a complication of trachoma. Trachoma remains the leading cause of infectious blindness globally, with Ethiopia being the most affected country in Africa. Trachomatous trichiasis occurs when repeated infections from trachoma lead to scarring on the inner eyelid, causing eyelashes to turn inward and scrape against the eye’s surface. The trial highlights ongoing challenges in managing complications associated with trachoma and underscores the need for further research into effective solutions for impacted populations.

Source: Ethiopian News January 13, 2026 00:37 UTC